BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
(Reuters) — Bayer now expects a U.S. judge to hold a hearing on May 12 on a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, a spokesman said Wednesday.
The German crop chemicals and seeds group had earlier said the matter was due to be heard by March 31. It now expects a court decision on the deal toward the end of the second quarter.
Bayer on Feb. 3 came to terms with plaintiffs’ lawyers in a $2 billion pledge to resolve future claims, as the products in question will remain on the market. That would add $750 million to the total bill of an outline settlement agreed to in June 2020, tallied at up to $11 billion at the time.
Some plaintiffs’ lawyers, who have so far opted out of the overall settlement, had lodged objections against the deal on future cases.
(Reuters) — Attorneys for Bayer AG and consumers suing the company over allegations its Roundup weedkiller caused cancer told a judge on Thursday they are continuing to resolve thousands more cases, improving prospects for its $11 billion deal to end the litigation.